![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
X
20
Zhejiang Bamboo Pharmaceuticals Co.,ltd. Shaoxing Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Gabapentin, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-027 - Rev 01
This Chemical Type CEP, issued on March 11, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2173 associated with this CEP further emphasizes